Paper39247602
DPP7 as a Potential Therapeutic Marker for Colorectal Cancer.
Ma L and 4 others. J Cancer, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. DPP7 as a Potential Therapeutic Marker for Colorectal Cancer. Papers, record 39247602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39247602
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36804124 | Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/36804124 | PubMed |
| 2 | 34459003 | Dynamic EMT: a multi-tool for tumor progression. | EMBO J | 2021 | https://conductscience.org/library/papers/34459003 | PubMed |
| 3 | 38454764 | DPP2/7 is a Potential Predictor of Prognosis and Target in Immunotherapy in Colorectal Cancer: An Integrative Multi-omics Analysis. | Comb Chem High Throughput Screen | 2024 | https://conductscience.org/library/papers/38454764 | PubMed |
| 4 | 32131763 | Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32131763 | PubMed |
| 5 | 36831614 | Hederacolchiside A1 Suppresses Autophagy by Inhibiting Cathepsin C and Reduces the Growth of Colon Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831614 | PubMed |
| 6 | 20817072 | Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. | Exp Hematol | 2010 | https://conductscience.org/library/papers/20817072 | PubMed |
| 7 | 37343412 | T follicular helper cells in cancer, tertiary lymphoid structures, and beyond. | Semin Immunol | 2023 | https://conductscience.org/library/papers/37343412 | PubMed |
| 8 | 33247170 | Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers. | Sci Rep | 2020 | https://conductscience.org/library/papers/33247170 | PubMed |
| 9 | 38341519 | Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/38341519 | PubMed |
| 10 | 28893231 | Involvement of DPP9 in gene fusions in serous ovarian carcinoma. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28893231 | PubMed |
| 11 | 27793569 | Dendritic Cells and Cancer Immunity. | Trends Immunol | 2016 | https://conductscience.org/library/papers/27793569 | PubMed |
| 12 | 31387239 | Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31387239 | PubMed |
| 13 | 32143683 | What is the effectiveness of various invitation methods to a colonoscopy in the early detection and prevention of colorectal cancer? Protocol of a systematic review. | Syst Rev | 2020 | https://conductscience.org/library/papers/32143683 | PubMed |
| 14 | 29967349 | DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. | Nat Med | 2018 | https://conductscience.org/library/papers/29967349 | PubMed |
| 15 | 33384961 | Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/33384961 | PubMed |
| 16 | 29414259 | CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. | Annu Rev Med | 2018 | https://conductscience.org/library/papers/29414259 | PubMed |
| 17 | 15258327 | Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer. | Dis Markers | 2003 | https://conductscience.org/library/papers/15258327 | PubMed |
| 18 | 28514441 | PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. | Nature | 2017 | https://conductscience.org/library/papers/28514441 | PubMed |
| 19 | 27943262 | Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC). | Int J Cancer | 2017 | https://conductscience.org/library/papers/27943262 | PubMed |
| 20 | 29733528 | Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases. | Cancer Med | 2018 | https://conductscience.org/library/papers/29733528 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947145 | The clinical value of 68Ga-FAPI to evaluate the peritoneal fibrosis and its inherent molecule relationship with POSTN and DPP7. | J Transl Med | 2026 | https://conductscience.org/library/papers/42947145 | PubMed |
| 42193335 | The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary Diseases. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193335 | PubMed |
| 41998312 | Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41998312 | PubMed |
| 41852731 | Plasma protein biomarkers predictive of progression to active tuberculosis among close contacts of patients with tuberculosis. | iScience | 2026 | https://conductscience.org/library/papers/41852731 | PubMed |
| 41208881 | DPP7 promotes fatty acid β-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/41208881 | PubMed |
| 41191200 | Prognostic significance of dipeptidyl peptidase-7 (DPP7) in HPV16-negative head and neck squamous cell carcinoma treated with induction chemoradiotherapy. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41191200 | PubMed |
| 40576169 | DPP7 Promotes Colorectal Cancer Progression Through GPX4-Dependent Suppression of Disulfidptosis and Immune Evasion. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40576169 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DPP7 | 29952 | PubTator's text mining | https://conductscience.org/library/genes/29952 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39247602
GET https://conductscience.org/api/papers/v1/39247602/references?page=2